Colorectal cancer in 2014: progress in defining first-line and maintenance therapies
- PMID: 25560533
- DOI: 10.1038/nrclinonc.2014.233
Colorectal cancer in 2014: progress in defining first-line and maintenance therapies
Abstract
The results of several clinical trials in metastatic colorectal cancer presented in 2014 will influence clinical practice. These findings include definitive data from phase III trials comparing bevacizumab and cetuximab-based therapy in the first-line, studies elucidating the value of maintenance therapy after induction treatment, and data on new agents in this disease.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical